Market Place
Sourcing Support
Health Canada Authorize 4Moving Biotech Phase 2a for Osteoarthritis
27 Mar 2025 //
BUSINESSWIRE
4Moving Biotech Appoints Luc Boblet As New Chief Executive Officer
02 Jul 2024 //
BUSINESSWIRE
4Moving Biotech Announces Positive Liraglutide Osteoarthritis Trial Results
10 Jun 2024 //
BUSINESSWIRE
4Moving Bio forms Advisory Board of World-Renowned Knee Osteoarthritis Experts
10 Nov 2023 //
BUSINESSWIRE
4Moving Completes Recruitment of Phase I Trial in Knee Osteoarthritis
19 Oct 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.